Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Long term evaluation of the safety and efficacy of local cooling anesthesia during intravitreal injections: The COOL-2 Trial.

PloS one·2026

Same author

Immunohistochemical clinicopathologic correlation and OCT analysis of idiopathic and secondary epiretinal membrane specimens.

International journal of ophthalmology·2026

Same author

Modalities of vision restoration in optic neuropathies and retinal disease.

Progress in retinal and eye research·2026

Same author

Secondary intraocular fixation: anterior vs. posterior segment approaches, middle segment surgery, and emerging artificial capsule technologies.

Current opinion in ophthalmology·2026

Same author

Retinal diseases: Current medical and surgical updates and a look to the future.

Current opinion in ophthalmology·2026

Same author

Influence of Social Determinants of Health on Presenting Visual Acuity in Retinal Vein Occlusions.

Ophthalmology science·2026

Same journal

Laser vision correction (LASIK, PRK, SMILE) with simultaneous accelerated corneal crosslinking.

Current opinion in ophthalmology·2026

Same journal

Traumatic macular hole: observe, operate, or other options.

Current opinion in ophthalmology·2026

Same journal

The evolving role of artificial intelligence in ophthalmology: basic science, translation, and clinical integration.

Current opinion in ophthalmology·2026

Same journal

Editorial: reducing risk for refractive surgery.

Current opinion in ophthalmology·2026

Same journal

Updates on Refractive Surgery: Benefits, Risks, and Costs of Modern Treatment Options.

Current opinion in ophthalmology·2026

Same journal

Corneal Allogeneic Intrastromal Ring Segments for keratoconus - recent evidence and the move to customized and custom shaped CAIRS.

Current opinion in ophthalmology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jul 4, 2025

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases

Published on: October 6, 2023

Cell therapy for retinal disease.

Goutham R Yalla^1,2, Ajay E Kuriyan¹

¹Wills Eye Hospital, Mid Atlantic Retina.

Current Opinion in Ophthalmology

|January 26, 2024

Summary

This summary is machine-generated.

Stem cell therapy shows promise for retinal diseases like macular degeneration and retinitis pigmentosa, but larger trials are needed to confirm efficacy. Patient education and regulation are crucial due to fraudulent clinics.

More Related Videos

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model

Published on: August 5, 2021

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye

Published on: November 25, 2012

Related Experiment Videos

Last Updated: Jul 4, 2025

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases

Published on: October 6, 2023

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model

Published on: August 5, 2021

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye

Published on: November 25, 2012

Area of Science:

Ophthalmology
Regenerative Medicine
Cell Biology

Background:

Stem cell therapy is being investigated for various retinal diseases.
Clinical trials have assessed its safety and role in conditions like age-related macular degeneration, Stargardt's macular dystrophy, and retinitis pigmentosa.

Conclusions:

Current clinical trials are characterizing the safety of stem cell therapy in retinal disease.
Larger, powered studies are necessary to definitively evaluate the efficacy of stem cell therapy for preventing retinal disease progression.
Regulation and patient education are essential to mitigate complications arising from unapproved stem cell therapy providers.